Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
…
5 pages
1 file
AI-generated Abstract
A recent headline suggested carbohydrates may be poisonous to diabetics, raising concerns among the 2.9 million diagnosed in the UK. While low-carbohydrate diets show potential for short-term benefits in weight loss and glycaemic control, evidence for long-term effectiveness compared to traditional approaches remains unclear. Current guidelines recommend individualized strategies for diabetes management, emphasizing the need for further research into the safety and efficacy of low-carbohydrate diets.
Diabetes Therapy, 2015
Introduction: Low carbohydrate diets are again in the spotlight and have been identified as particularly appropriate for people with type 2 diabetes. There is confusion amongst both health professionals and people with diabetes about the suitability of these diets. This review aims to provide an overview of the latest evidence and to explore the role of low carbohydrate diets for people with type 2 diabetes. Methods: An electronic search of English language articles was performed using MEDLINE (2010-May 2015), EMBASE (2010-May 2015), and the Cochrane Central Register of Controlled Trials (2010-May 2015). Only randomized controlled trials comparing interventions evaluating reduced carbohydrate intake with higher carbohydrate intake in people with diagnosed type 2 diabetes were included. Primary outcomes included weight, glycated hemoglobin, and lipid concentrations. Results: Low carbohydrate diets in people with type 2 diabetes were effective for short-term improvements in glycemic control, weight loss, and cardiovascular risk, but this was not sustained over the longer term. Overall, low carbohydrate diets failed to show superiority over higher carbohydrate intakes for any of the measures evaluated including weight loss, glycemic control, lipid concentrations, blood pressure, and compliance with treatment. Conclusion: Recent studies suggest that low carbohydrate diets appear to be safe and effective over the short term, but show no statistical differences from control diets with higher carbohydrate content and cannot be recommended as the default treatment for people with type 2 diabetes.
The New Zealand medical journal, 2016
Humans can derive energy from carbohydrate, fat, or protein. The metabolism of carbohydrate requires by far the highest secretion of insulin. The central pathology of diabetes is the inability to maintain euglycaemia because of a deficiency in either the action or secretion of insulin. That is, because of either insulin resistance often accompanied by hyperinsulinaemia, or insulin deficiency caused by pancreatic beta cell failure. In individuals dependent on insulin and other hypoglycaemic medication, the difficulty of matching higher intakes of carbohydrates with the higher doses of medication required to maintain euglycaemia increases the risk of adverse events, including potentially fatal hypoglycaemic episodes. Thus, mechanistically it has always made sense to restrict carbohydrate (defined as sugar and starch, but not soluble and insoluble fibre) in the diets of people with diabetes. Randomised clinical trials have confirmed that this action based on first principles is effecti...
2020
Introduction: Type 2 diabetes is characterized by a chronic metabolic disorder associated with relative insulin deficiency arising as a result of the secretion defect and / or insulin resistance. Today, the disorder is classified as a civilization disease and its incidence continues to increase. Objectives of the study: The purpose of the presented study is to verify the current state of knowledge concerning usage of low-carbohydrate diets in type 2 diabetes, and to present the benefits and risks associated with the given nutrition in these patients.
International Journal of Clinical Trials, 2022
Background: Type 1 diabetes mellitus is an autoimmune disease characterized by the destruction of pancreatic beta cells and absolute insulin deficiency. After the discovery of insulin, guidelines recommended 50% to 60% of carbohydrate consumption in individuals with diabetes. However, this recommendation is ineffective, since carbohydrate is the macronutrient that causes the greatest increase in blood glucose. The aim of this research is to evaluate the efficacy of a low-carbohydrate diet in adults with type 1 diabetes mellitus.Methods: The study is a 26 weeks clinical trial. During the first 15 days, participants will receive approximately 130 g of daily carbohydrates, followed by a phase of 7 days, with the consumption of 90 g of daily carbohydrates, and finally, the consumption of 50 g of carbohydrates. The target audience is 20 participants diagnosed with type 1 diabetes mellitus, glycated hemoglobin (HbA1c) >7.0% and aged between 21 and 50 years, in addition to the parameter...
Diet is one of the main therapies for patients with type 2 diabetes mellitus (T2DM). Many studies have investigated the relationship and risks between diet lifestyle, carbohydrate intake, and diabetes. It is not known exactly how diets, along with medication, affect medication during the treatment of diabetes mellitus. The purpose of this review is to summarize studies investigating the interaction of low-carbohydrate diets (LCD) and diabetes mellitus medication.
Canadian Journal of Diabetes, 2006
Low-carbohydrate diets are popular amongs individuals with type 2 diabetes to achieve weight loss. These diets recommend lower carbohydrate intakes (<45% of energy) than current nutritional recommendations. This evidence-based review aims to determine the potential benefits and risks associated with their use for weight management and glycemic control. Emerging evidence suggests that in the short term (within 6 months), when substituted for a conventional low-fat diet, low-carbohydrate diets can result in greater weight loss and better glycemic control, without a negative effect on blood lipids.There is, however, insufficient research to evaluate long-term risks or benefits. Individuals with type 2 diabetes who significantly restrict food groups or specific foods should have their diets assessed for fibre, antioxidant, nutrient and folate content.
Journal of Human Nutrition and Dietetics, 2008
Background Recent evidence from randomized controlled trials of hypocaloric low carbohydrate diets in people without diabetes has shown that they promote significant weight loss over the short term. There is very little evidence for any effects of reduced carbohydrate intakes on body weight, glycaemia and cardiovascular risk in people with type 2 diabetes. Methods An electronic search was performed using MEDLINE (1966 to March 2007), EMBASE (1988 to March 2007) and Cochrane Central Register of Controlled Trials (1991 to March 2007) using the keywords low carbohydrate, type 2 diabetes and weight loss. Studies including subjects with type 2 diabetes who adopted a reduced carbohydrate weight loss diet were identified. Data were extracted on study design, weight loss, effects on glycaemia and cardiovascular risk and potential adverse effects. Results Six studies investigating the effects of hypocaloric reduced carbohydrate diets in people with type 2 diabetes were identified. The studies were heterogenous and most included small numbers, were short-term and provided varying amounts of carbohydrate. No studies were identified that were both low carbohydrate (<50 g day)1) and also designed as randomized controlled trials. All studies reported reductions in both body weight and glycated haemoglobin, with no deleterious effects on cardiovascular risk, renal function or nutritional intake. Conclusions Conclusions are limited by study design and small numbers, but it appears that reduced carbohydrate diets are safe and effective over the short term for people with type 2 diabetes.
Nutrition & Metabolism, 2008
Background: Low-carbohydrate diets, due to their potent antihyperglycemic effect, are an intuitively attractive approach to the management of obese patients with type 2 diabetes. We previously reported that a 20% carbohydrate diet was significantly superior to a 55-60% carbohydrate diet with regard to bodyweight and glycemic control in 2 groups of obese diabetes patients observed closely over 6 months (intervention group, n = 16; controls, n = 15) and we reported maintenance of these gains after 22 months. The present study documents the degree to which these changes were preserved in the low-carbohydrate group after 44 months observation time, without close follow-up. In addition, we assessed the performance of the two thirds of control patients from the high-carbohydrate diet group that had changed to a low-carbohydrate diet after the initial 6 month observation period. We report cardiovascular outcome for the lowcarbohydrate group as well as the control patients who did not change to a low-carbohydrate diet. Method: Retrospective follow-up of previously studied subjects on a low carbohydrate diet. Results: The mean bodyweight at the start of the initial study was 100.6 ± 14.7 kg. At six months it was 89.2 ± 14.3 kg. From 6 to 22 months, mean bodyweight had increased by 2.7 ± 4.2 kg to an average of 92.0 ± 14.0 kg. At 44 months average weight has increased from baseline g to 93.1 ± 14.5 kg. Of the sixteen patients, five have retained or reduced bodyweight since the 22 month point and all but one have lower weight at 44 months than at start. The initial mean HbA1c was 8.0 ± 1.5%. After 6, 12 and 22 months, HbA1c was 6.1 ± 1.0%, 7.0 ± 1.3% and 6.9 ± 1.1% respectively. After 44 months mean HbA1c is 6.8 ± 1.3%. Of the 23 patients who have used a low-carbohydrate diet and for whom we have long-term data, two have suffered a cardiovascular event while four of the six controls who never changed diet have suffered several cardiovascular events. Conclusion: Advice to obese patients with type 2 diabetes to follow a 20% carbohydrate diet with some caloric restriction has lasting effects on bodyweight and glycemic control.
The American journal of clinical nutrition, 2015
Few well-controlled studies have comprehensively examined the effects of very-low-carbohydrate diets on type 2 diabetes (T2D). We compared the effects of a very-low-carbohydrate, high-unsaturated fat, low-saturated fat (LC) diet with a high-carbohydrate, low-fat (HC) diet on glycemic control and cardiovascular disease risk factors in T2D after 52 wk. In this randomized controlled trial that was conducted in an outpatient research clinic, 115 obese adults with T2D [mean ± SD age: 58 ± 7 y; body mass index (in kg/m(2)): 34.6 ± 4.3; glycated hemoglobin (HbA1c): 7.3 ± 1.1%; duration of diabetes: 8 ± 6 y] were randomly assigned to consume either a hypocaloric LC diet [14% of energy as carbohydrate (carbohydrate <50 g/d), 28% of energy as protein, and 58% of energy as fat (<10% saturated fat)] or an energy-matched HC diet [53% of energy as carbohydrate, 17% of energy as protein, and 30% of energy as fat (<10% saturated fat)] combined with supervised aerobic and resistance exercis...
AABNER, 2023
In this article, I discuss the reception and espousal of Gentile ethnicity in late antique Arabia and the Quran. I suggest that the Prophet Muhammad and many of his followers identified as Gentile (ummī or ḥanīf) believers, which they portrayed as carrying positive significations. I discuss various ancient and late ancient Christian texts that appear to be in the background of this development. I argue that the Quran recategorizes Jewish, Christian, and Gentile believers (here: those who believed in the Prophet Muhammad’s mission and accepted it) as belonging to the same community of believers. The figure of Abraham is of utmost importance in the ethnic reasoning of the Quran.
Metal Ages / Âges des métaux, 2023
SSRN, 2024
Pacific Affairs, Vol. 83, No. 4, 2010
Pensamiento Crítico, 2023
CAMBRIDGE SCHOLARS PUBLISHING, 2015
Journal of Water Management Modeling, 2015
Open Journal of Philosophy, 2012
Mediterranean Journal of Social Sciences, 2014
in En Languedoc au XIIIe s. Le temps du sac de Béziers, dir. M. BOURIN, 2010
IAEME PUBLICATION, 2024
Old World: Journal of Ancient Africa and Eurasia
Neuropsychopharmacology, 2017
ASA Special Publication, 1997
Eating Disorders, 2013
Open Geosciences, 2017
Global Food Security, 2019
The Journal of medical research, 2018